Skip to main content
TipRanks
Go Ultimate75% OFF
GelMEDIX logo

GelMEDIX: Valuation, Funding & Investors

LabCentral Cambridge, MA 02139, UShttps://www.gelmedix.com/Therapeutics

GelMEDIX is a biotechnology company developing regenerative therapies to restore vision, focusing on cell-based treatments and biomaterials for retinal diseases. The company is advancing GMX-101, an RPE cell therapy for late-stage Geographic Atrophy, and a proprietary injectable hydrogel scaffold platform engineered to optimize delivery, efficacy, and safety of cell and gene therapies.

Leadership & Board

Current Number of Employees
9
Current LinkedIn Followers
1,159

Latest Estimated Valuation

Total Amount Raised
$13M
Total Funding Rounds
1
Latest Funding Amount
$13M
Latest Funding Round
Seed Round

Employee Trend

GelMEDIX had 9 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

9Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

GelMEDIX had 1,159 followers as of November 16, 2026. The number of followers increased by 1 (0.09%) week-over-week.

1,159Latest Followers Count
1(0.09%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Feb 17, 2026Seed Round$13.00M―

Investors

Investor NameFunding Round
Beacon AngelsSeed Round
Boston Harbor AngelsSeed Round
HTL BiotechnologySeed Round
Safar PartnersSeed Round
TiE Boston AngelsSeed Round

Similar Companies

A snapshot of private companies similar to GelMEDIX, helping you discover and navigate related company profiles.

Related News and Analysis